UK Markets open in 5 mins
NIKKEI 225
29,839.71-660.34(-2.17%)HANG SENG
24,087.22-11.92(-0.05%)CRUDE OIL
71.20+0.91(+1.29%)GOLD FUTURES
1,762.40-1.40(-0.08%)DOW
33,970.47-614.41(-1.78%)BTC-GBP
32,565.74-2,671.21(-7.58%)
Aclaris Therapeutics, Inc. (0H8T.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
19.09+2.41 (+14.45%)
At close: 6:01PM BST
| Previous close | 16.68 |
| Open | 18.44 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 18.44 - 18.44 |
| 52-week range | 18.44 - 18.44 |
| Volume | 100 |
| Avg. volume | N/A |
| Market cap | 558.245M |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.43 |
| Earnings date | 05 Aug 2021 - 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
The 9.4% return this week takes Aclaris Therapeutics' (NASDAQ:ACRS) shareholders one-year gains to 510%
Some Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) shareholders are probably rather concerned to see the share price fall...
- Zacks
Should You Buy Aclaris Therapeutics (ACRS) Ahead of Earnings?
Aclaris Therapeutics (ACRS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Aclaris (ACRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2021 Verizon Media. All rights reserved.
